CRKL binding to BCR-ABL and BCR-ABL transformation

Leukemia and Lymphoma

Volumn 33, Issue 1-2, 1999, Pages 119-126

  Kolibaba, Kathryn S ^a   Bhat, Arun ^a   Heaney, Conor ^a   Oda, Tsukasa ^a,b   Druker, Brian J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Helix Research Institute Inc   (Japan)

Author keywords

BCR ABL; CRKL; Src homology domains; Tyrosine phosphorylation

Indexed keywords

ADAPTOR PROTEIN; BCR ABL PROTEIN; GROWTH FACTOR; PHOSPHOPROTEIN; PROLINE;

AMINO TERMINAL SEQUENCE; ARTICLE; ASSAY; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL STRAIN K 562; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; DELETION MUTANT; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 0033007404     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909093732     Document Type: Article

References (39)

1. Nowell, P. C. and Hungerford, D. A. (1960) A minute chromosome in human granulocytic leukemia. Science, 132, 1497-1501.
2. Groffen, J., Stephenson, J. R., Heisterkamp, N., de Klein, A., Bartram, C. R. and Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell, 36, 93-99.
3. Heisterkamp, N., Stam, K., Groffen, J., de Klein, A. and Grosveld, G. (1985) Structural organization of the bcr gene and its role in the Ph' translocation. Nature, 315, 758-761.
4. Ben-Neriah, Y., Daley, G. Q., Mes-Masson, A. M., Witte, O. N. and Baltimore, D. (1986) The chronic myelogenous leukemia-specific p210 protein is the product of the bcr/abl hybrid gene. Science, 233, 212-214.
5. Daley, G. Q., McLaughlin, J., Witte, O. N. and Baltimore, D. (1987) The CML-specific P210 ber/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science, 237, 532-535.
6. Davis, R. L., Konopka, J. B. and Witte, O. N. (1985) Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Molecular and Cellular Biology, 5, 204-213.
7. Lugo, T., Pendergast, A.-M., Muller, A. J. and Witte, O. N. (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science, 247, 1079-1082.
8. Oda, T., Tamura, S., Matsuguchi, T., Griffin, J. D. and Druker, B. J. (1995) The SH2 domain of ABL is not required for factor-independent growth induced by BCR-ABL in a murine myeloid line. Leukemia, 9, 295-301.
9. McLaughlin, J., Chianese, E. and Witte, O. N. (1987) In vitro transformation of immature hematopoietic cells by the P210BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA, 84,6558-6562.
10. Young, J. C. and Witte, O. N. (1988) Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures. Mol Cell Biol, 8, 4079-4087.
11. Daley, G. Q. and Baltimore, D. (1988) Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci USA, 85, 9312-9316.
12. Rosenberg, N. (1990) Murine models for human chronic myelogenous leukemia. Cancer Cells, 2, 284-286.
13. Daley, G. Q., Van Etten, R. A. and Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-830.
14. Kelliher, M. A., McLaughlin, J., Witte, O. N. and Rosenberg, N. (1990) Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA, 87, 6649-6653.
15. Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J. and Gishizky, M. (1993) BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adapator protein. Cell, 75, 175-185.
16. Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P. G., Arlinghaus, R. and Pawson, T. (1994) Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO Journal, 13, 764-773.
17. Matsuguchi, T., Salgia, R , Hallek, M., Eder, M., Druker, B., Ernst, T. and Griffin, J. D. (1994) SHC phosphorylation in myeloid cells is regulated by GM-CSF, IL-3, and steel factor and is constitutively increased by p210Bcr/Abl. Journal of Biological Chemistry, 269, 5016-5021.
18. Tauchi, T., Boswell, H. S., Leiboweitz, D. and Broxmeyer, H. E. (1994) Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. Journal of Experimental Medicine, 179, 167.
19. Druker, B., Okuda, K., Matulonis, U., Salgia, R., Roberts, T. and Griffin, J. D. (1992) Tyrosine phosphorylation of ras-GAP and associated proteins in chronic myelogenous leukemia cell lines. Blood, 79, 2215-2220.
20. Andoniou, C. E., Thien, C. B. F. and Langdon, W. Y. (1994) Tumour induction by activated abl involves the tyrosine phosphorylation of the product of the cbl oncogene. EMBO Journal, 13, 4515-4523.
21. de Jong, R., ten Hoeve, J., Heisterkamp, N. and Groffen, J. (1995) Crkl is complexed with tyrosine-phosphorylated cbl in Ph-positive leukemia. Journal of Biological Chemistry, 270, 21468-21471.
22. Ribon, V., Hubbell, S., Herrera, R. and Saltiel, A. R. (1996) The product of the cbl oncogene forms stable complexes in vivo with endogenous crk in a tyrosine phosphorylation-dependent manner. Molecular and Cellular Biology, 16, 45-52.
23. Varticovski, L., Daley, G. Q., Jackson, P. Baltimore, D. and Cantley, L. (1991) Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants. Molecular and Cellular Biology, 11, 1107-1113.
24. ten Hoeve, J., Arlinghaus, J. Q. G., Heisterkamp, N. and Groffen, J. (1994) Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood, 84, 1731-1736.
25. Carpino, N., Wisniewski, D., Strife, A., Marshak, D., Kobayashi, R., Stillman, B. and Clarkson, B. (1997) p62dok: A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell, 88, 197-204.
26. Yamanashi, Y. and Baltimore, D. (1997) Identification of the ABL- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell, 88, 205-211.
27. Nichols, G. L., Raines, M. A., Vera, J. C., Lacomis, L., Tempst, P. and Golde, D. W. (1994) Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood, 84, 2912-2918.
28. Oda, T., Heaney, C., Hagopian, J. R., Okuda, K., Griffin, J. D. and Druker, B. J. (1994) CRKL is the major tyrosine phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. Journal of Biological Chemistry, 269, 22925-22928.
29. Mayer, B., Hamaguchi, M. and Hanafusa, H. (1988) A novel viral oncogene with structural similarity to phospholipase C. Nature, 332, 272-275.
30. Senechal, K., Halpern, J. and Sawyers, C. L. (1996) The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene. J Biol Chem, 271, 23255-23261.
31. Heaney, C., Kolibaba, K., Bhat, A., Oda, T., Ohno, S., Fanning, S. and Druker, B. J. (1997) Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation Blood, 89, 297-306.
32. ten Hoeve, J., Kaartinen, V., Fioretos, T., Haataja, L., Voncken, J.-W., Heisterkamp, N. and Groffen, J. (1994) Cellular interactions of CRKL, an SH2-SH3 adaptor protein. Cancer Research, 54, 2563-2567.
33. Vojtek, A. B., Hollenberg, S. M. and Cooper, J. A. (1993) Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell, 74, 205-214.
34. Ren, R., Ye, Z.-S. and Baltimore, D. (1994) Abl protein-tyrosine kinase selects the Crk adaptor as a substrate using SH3 domains. Genes and Development, 8, 783-795.
35. Bhat, A., Kolibaba, K., Oda, T., Ohno-Jones, S., Heaney, C. and Druker, B. J. (1997) Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells. J Biol Chem, 272, 16170-16175.
36. Jain, S. K., Susa, M., Keeler, M. L., Carlesso, N., Druker, B. and Varticovski, L. (1996) PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl. Blood, 88, 1542-1550.
37. Feller, S. M., Knudsen, B. and Hanafusa, H. (1995) Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways. Oncogene, 10, 1465-1473.
38. Bhat, A., Johnson, K., Oda, T. and Druker, B. J. (1998) Interactions of p62dok with p210bcr-abl and Bcr-Abl-associated proteins. submitted.
39. Salgia, R., Li, J. L., Lo, S. H., Brunkhorst, B., Kansas, G. S., Sobhany, E. S., Sun, Y., Pisick, E., Hallek, M., Ernst, T., Chen, L. B. and Griffin, J. D. (1995) Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. Journal of Biological Chemistry, 270, 5039-5047.